Incyte to Present at J.P. Morgan Conference on January 12, 2026
Incyte (Nasdaq: INCY) is set to present at the 44th Annual J.P. Morgan Healthcare Conference on January 12, 2026. This event, a key fixture in the biopharmaceutical calendar, will take…
Incyte Board Transition Signals New Era After Hoppenot’s Exit
Incyte Corporation (Nasdaq: INCY) has announced that Hervé Hoppenot has resigned from its board of directors, effective immediately. This decision marks a significant transition for the company, concluding Hoppenot’s long-standing…